Latest Breaking News On - Managing director krishna - Page 2 : comparemela.com

Bharat Biotech to make antigen for first-ever anti-malaria vaccine ​ By IANS | Published on ​ Wed, Jan 27 2021 18:42 IST | ​ 0 Views Over 60 envoys visit Bharat Biotech facility in Hyderabad. Image Source: IANS News Hyderbad, Jan 27 : Global healthcare company GSK, non-profit agency working to end health inequity PATH, and vaccine maker Bharat Biotech on Wednesday announced the signing of a product transfer agreement for malaria vaccine RTS,S/AS01E1. The agreement includes the transfer of manufacturing of the RTS,S antigen part of the vaccine and the grant of a license on all rights pertaining to the RTS,S/AS01 malaria vaccine to Hyderabad-based Bharat Biotech International Ltd (BBIL). GSK will retain the production of the adjuvant of the vaccine (AS01E) and will supply it to Bharat Biotech.

Thomas breuerKrishnam ellaJohn bawaEuropean medicines agencyMalaria vaccine implementation programmeVaccines global healthMinistries of healthBharat biotech international ltdWorld health organisationBharat biotechHyderabad based bharat biotech international ltdChief medical officerAfrica leadsVaccine implementationBiotech chairmanManaging director krishna